ArticleInternational medical case reports journal2025
Neurological Sequelae After Sacral Radiofrequency Ablation: A Case of Acute Cauda Equina Syndrome.
Article in International medical case reports journal, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Radiofrequency ablation (RFA) is a minimally invasive technique that uses high-frequency electrical currents to generate heat, causing controlled destruction of targeted tissues through ionic agitation. RFA-associated neuropathy is a rare but recognized complication. We present a case of cauda equina syndrome and sensorimotor neuropathy following RFA of a sacral bone metastasis. Electromyography confirmed peripheral neuropathy, particularly affecting the peroneal nerve, and MRI revealed degenerative changes and a pelvic mass near the sacrum. The patient was treated with corticosteroids and neurotrophic supplementation and subsequently discharged for oncology follow-up. This case highlights the potential for RFA-induced neuropathy, emphasizing the need for careful procedural planning, post-treatment monitoring, and further research on the role of corticosteroids in mitigating neurological complications. This finding also raises questions about the role of corticosteroids in managing such complications, emphasizing the need for personalized care and further research to improve patient outcomes.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.